The United States Patent and Trademark Office has issued a patent to Glaukos for shunt devices to treat glaucoma and the method of implanting those devices, according to a company press release.
The patent, titled “Shunt Device and Method for Treating Ocular Disorders,” covers both ocular devices and methods of surgically implanting those devices within Schlemm’s canal to facilitate aqueous humor flow, the release said.
“This issued patent strengthens the protection of our inventions, further substantiates the proprietary nature of our technology and further expands our
Uncategorized